Literature DB >> 8155866

Histopathology of portal tracts in livers after transcatheter arterial chemo-embolization therapy for hepatocellular carcinoma.

S Kobayashi1, Y Nakanuma, O Matsui.   

Abstract

To study the influence of transcatheter arterial embolization therapy (TAE) on the portal tracts, 32 cases of hepatocellular carcinoma (HCC) with a history of TAE were examined. Portal tract elements are said to be mainly supplied by hepatic arterial blood, as is HCC. The following changes were found: peribile duct fibrosis; biliary epithelial injuries; bile duct necrosis; fibrous thickening of the intima and adventitia of arteries; thrombosis or stenosis of portal vein branches; and fibrosis of portal tract itself. We failed to correlate these histopathologic changes with the frequency of TAE or the interval between TAE therapy and surgery or autopsy. Semi-quantitative assessment disclosed that vessels of the peribiliary vascular plexus (PVP) which are known to be derived from hepatic arterial branches, were considerably decreased. There was little correlation between the degree of reduction of PVP and the observed histopathologic changes of portal tracts. It is suggested that TAE causes adverse effects on the elements of portal tracts and a reduction in the PVP in the vicinity of HCC, but the relationship between them is unclear.

Entities:  

Mesh:

Year:  1994        PMID: 8155866     DOI: 10.1111/j.1440-1746.1994.tb01215.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  6 in total

1.  Hepatic perfusion changes after transcatheter arterial embolization (TAE) of hepatocellular carcinoma: measurement by dynamic computed tomography (CT).

Authors:  Y Tsushima; Y Unno; J Koizumi; S Kusano
Journal:  Dig Dis Sci       Date:  1998-02       Impact factor: 3.199

2.  Portal hypertension is associated with poor outcome of transarterial chemoembolization in patients with hepatocellular carcinoma.

Authors:  Jin Woo Choi; Jin Wook Chung; Dong Ho Lee; Hyo-Cheol Kim; Saebeom Hur; Myungsu Lee; Hwan Jun Jae
Journal:  Eur Radiol       Date:  2017-12-07       Impact factor: 5.315

3.  Evaluation of Liver and Renal Toxicity in Peptide Receptor Radionuclide Therapy for Somatostatin Receptor Expressing Tumors: A 2-Year Follow-Up.

Authors:  Heying Duan; Valentina Ferri; George Albert Fisher; Shagufta Shaheen; Guido Alejandro Davidzon; Andrei Iagaru; Carina Mari Aparici
Journal:  Oncologist       Date:  2022-06-08       Impact factor: 5.837

4.  Effect of bead size and doxorubicin loading on tumor cellular injury after transarterial embolization and chemoembolization in a rat model of hepatocellular carcinoma.

Authors:  Andrea C Cortes; Hideyuki Nishiofuku; Urszula Polak; Adeeb A Minhaj; Mirtha S Lopez; Kimihiko Kichikawa; Aliya Qayyum; Elizabeth M Whitley; Rony Avritscher
Journal:  Nanomedicine       Date:  2021-09-24       Impact factor: 6.096

5.  Hepatic parenchymal changes following transcatheter embolization and chemoembolization in a rabbit tumor model.

Authors:  Yong Wang; Bin Xiong; Bin Liang; Hui Zhao; Hui Li; Jun Qian; Hui-Min Liang; Gan-Sheng Feng; Chuan-Sheng Zheng
Journal:  PLoS One       Date:  2013-08-14       Impact factor: 3.240

Review 6.  Pathophysiology and Imaging Findings of Bile Duct Necrosis: A Rare but Serious Complication of Transarterial Therapy for Liver Tumors.

Authors:  Satoshi Kobayashi; Kazuto Kozaka; Toshifumi Gabata; Osamu Matsui; Wataru Koda; Miho Okuda; Kenichiro Okumura; Takumi Sugiura; Takahiro Ogi
Journal:  Cancers (Basel)       Date:  2020-09-11       Impact factor: 6.639

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.